AVITA Medical, Inc. (AVHHL)
OTCMKTS · Delayed Price · Currency is USD
0.8125
-0.1875 (-18.75%)
At close: Aug 8, 2025
AVITA Medical Market Cap
AVITA Medical has a market cap or net worth of $146.45 million as of August 25, 2025. Its market cap has decreased by -29.56% in one year.
Market Cap
146.45M
Enterprise Value
175.35M
Revenue
74.88M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.81
Market Cap Chart
Since March 29, 2012, AVITA Medical's market cap has increased from 59.55M to 146.45M, an increase of 145.95%. That is a compound annual growth rate of 6.94%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 22, 2025 | 146.45M | -56.70% |
| Dec 31, 2024 | 338.19M | -4.00% |
| Dec 29, 2023 | 352.28M | 111.74% |
| Dec 30, 2022 | 166.38M | -44.28% |
| Dec 31, 2021 | 298.61M | -25.68% |
| Dec 31, 2020 | 401.79M | -58.30% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.93M |
| Veradigm | 823.67M |
| Tian'an Technology Group | 682.77M |
| Glass House Brands | 634.05M |
| Elite Pharmaceuticals | 587.83M |
| American Oncology Network | 382.44M |
| CytoDyn | 372.36M |
| Northwest Biotherapeutics | 366.64M |